Protagonist Therapeutics
PTGX
PTGX
69 hedge funds and large institutions have $93.6M invested in Protagonist Therapeutics in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 70 → 69 (-1)
9% less capital invested
Capital invested by funds: $103M → $93.6M (-$8.9M)
Holders
69
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.9M | |
| 2 | +$6.8M | |
| 3 | +$2.86M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.88M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.53M |
Top Sellers
| 1 | -$9.31M | |
| 2 | -$3.36M | |
| 3 | -$2.91M | |
| 4 |
PI
Pharmstandard International
Luxembourg
|
-$1.56M |
| 5 |
State Street
Boston,
Massachusetts
|
-$925K |